Global Plasma Protein Therapeutics Market Research Report 2024
Table of Contents1 Plasma Protein Therapeutics Market Overview
1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Plasma Protein Therapeutics Segment by Type
1.2.1 Global Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Plasma Protein Therapeutics Segment by Application
1.3.1 Global Plasma Protein Therapeutics Market Value by Application: (2024-2030)
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Plasma Protein Therapeutics Revenue 2019-2030
1.4.2 Global Plasma Protein Therapeutics Sales 2019-2030
1.4.3 Global Plasma Protein Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Protein Therapeutics Market Competition by Manufacturers
2.1 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Protein Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Protein Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Protein Therapeutics, Product Type & Application
2.7 Plasma Protein Therapeutics Market Competitive Situation and Trends
2.7.1 Plasma Protein Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue
2.7.3 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Protein Therapeutics Retrospective Market Scenario by Region
3.1 Global Plasma Protein Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Protein Therapeutics Global Plasma Protein Therapeutics Sales by Region: 2019-2030
3.2.1 Global Plasma Protein Therapeutics Sales by Region: 2019-2024
3.2.2 Global Plasma Protein Therapeutics Sales by Region: 2025-2030
3.3 Global Plasma Protein Therapeutics Global Plasma Protein Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Plasma Protein Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Plasma Protein Therapeutics Revenue by Region: 2025-2030
3.4 North America Plasma Protein Therapeutics Market Facts & Figures by Country
3.4.1 North America Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Protein Therapeutics Sales by Country (2019-2030)
3.4.3 North America Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plasma Protein Therapeutics Market Facts & Figures by Country
3.5.1 Europe Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Protein Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Protein Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plasma Protein Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Protein Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Plasma Protein Therapeutics Sales by Type (2019-2030)
4.1.1 Global Plasma Protein Therapeutics Sales by Type (2019-2024)
4.1.2 Global Plasma Protein Therapeutics Sales by Type (2025-2030)
4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Plasma Protein Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Plasma Protein Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Plasma Protein Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Protein Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Protein Therapeutics Sales by Application (2019-2030)
5.1.1 Global Plasma Protein Therapeutics Sales by Application (2019-2024)
5.1.2 Global Plasma Protein Therapeutics Sales by Application (2025-2030)
5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Plasma Protein Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Plasma Protein Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Protein Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shire (Baxalta)
6.1.1 Shire (Baxalta) Corporation Information
6.1.2 Shire (Baxalta) Description and Business Overview
6.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
6.1.5 Shire (Baxalta) Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Plasma Protein Therapeutics Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Plasma Protein Therapeutics Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Plasma Protein Therapeutics Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Plasma Protein Therapeutics Description and Business Overview
6.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Kamada
6.12.1 Kamada Corporation Information
6.12.2 Kamada Plasma Protein Therapeutics Description and Business Overview
6.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
6.12.5 Kamada Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Protein Therapeutics Industry Chain Analysis
7.2 Plasma Protein Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Protein Therapeutics Production Mode & Process
7.4 Plasma Protein Therapeutics Sales and Marketing
7.4.1 Plasma Protein Therapeutics Sales Channels
7.4.2 Plasma Protein Therapeutics Distributors
7.5 Plasma Protein Therapeutics Customers
8 Plasma Protein Therapeutics Market Dynamics
8.1 Plasma Protein Therapeutics Industry Trends
8.2 Plasma Protein Therapeutics Market Drivers
8.3 Plasma Protein Therapeutics Market Challenges
8.4 Plasma Protein Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesTable 1. Global Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Plasma Protein Therapeutics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Plasma Protein Therapeutics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Plasma Protein Therapeutics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Plasma Protein Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Plasma Protein Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma Protein Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Plasma Protein Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 19. Global Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)
Table 20. Global Plasma Protein Therapeutics Sales Market Share by Region (2025-2030)
Table 21. Global Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 23. Global Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Plasma Protein Therapeutics Revenue Market Share by Region (2025-2030)
Table 25. North America Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 27. North America Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 28. North America Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Plasma Protein Therapeutics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Plasma Protein Therapeutics Sales (K Units) by Type (2019-2024)
Table 51. Global Plasma Protein Therapeutics Sales (K Units) by Type (2025-2030)
Table 52. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 53. Global Plasma Protein Therapeutics Sales Market Share by Type (2025-2030)
Table 54. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 57. Global Plasma Protein Therapeutics Revenue Market Share by Type (2025-2030)
Table 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 59. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2025-2030)
Table 60. Global Plasma Protein Therapeutics Sales (K Units) by Application (2019-2024)
Table 61. Global Plasma Protein Therapeutics Sales (K Units) by Application (2025-2030)
Table 62. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 63. Global Plasma Protein Therapeutics Sales Market Share by Application (2025-2030)
Table 64. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 67. Global Plasma Protein Therapeutics Revenue Market Share by Application (2025-2030)
Table 68. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2024)
Table 69. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2025-2030)
Table 70. Shire (Baxalta) Corporation Information
Table 71. Shire (Baxalta) Description and Business Overview
Table 72. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Shire (Baxalta) Plasma Protein Therapeutics Product
Table 74. Shire (Baxalta) Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. CSL Plasma Protein Therapeutics Product
Table 79. CSL Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Grifols Plasma Protein Therapeutics Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Octapharma Plasma Protein Therapeutics Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Corporation Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Kedrion Plasma Protein Therapeutics Product
Table 94. Kedrion Recent Developments/Updates
Table 95. LFB Group Corporation Information
Table 96. LFB Group Description and Business Overview
Table 97. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. LFB Group Plasma Protein Therapeutics Product
Table 99. LFB Group Recent Developments/Updates
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Biotest Plasma Protein Therapeutics Product
Table 104. Biotest Recent Developments/Updates
Table 105. BPL Corporation Information
Table 106. BPL Description and Business Overview
Table 107. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BPL Plasma Protein Therapeutics Product
Table 109. BPL Recent Developments/Updates
Table 110. RAAS Corporation Information
Table 111. RAAS Description and Business Overview
Table 112. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. RAAS Plasma Protein Therapeutics Product
Table 114. RAAS Recent Developments/Updates
Table 115. CBPO Corporation Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. CBPO Plasma Protein Therapeutics Product
Table 119. CBPO Recent Developments/Updates
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Business Overview
Table 122. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Hualan Bio Plasma Protein Therapeutics Product
Table 124. Hualan Bio Recent Developments/Updates
Table 125. Kamada Corporation Information
Table 126. Kamada Description and Business Overview
Table 127. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Kamada Plasma Protein Therapeutics Product
Table 129. Kamada Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Plasma Protein Therapeutics Distributors List
Table 133. Plasma Protein Therapeutics Customers List
Table 134. Plasma Protein Therapeutics Market Trends
Table 135. Plasma Protein Therapeutics Market Drivers
Table 136. Plasma Protein Therapeutics Market Challenges
Table 137. Plasma Protein Therapeutics Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Plasma Protein Therapeutics
Figure 2. Global Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Plasma Protein Therapeutics Market Share by Type in 2023 & 2030
Figure 4. Coagulation Factor Product Picture
Figure 5. Immune Globulin Product Picture
Figure 6. Albumin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Plasma Protein Therapeutics Market Share by Application in 2023 & 2030
Figure 10. Hemophilia
Figure 11. PID
Figure 12. Others
Figure 13. Global Plasma Protein Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Plasma Protein Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 15. Global Plasma Protein Therapeutics Sales (2019-2030) & (K Units)
Figure 16. Global Plasma Protein Therapeutics Average Price (USD/Unit) & (2019-2030)
Figure 17. Plasma Protein Therapeutics Report Years Considered
Figure 18. Plasma Protein Therapeutics Sales Share by Manufacturers in 2023
Figure 19. Global Plasma Protein Therapeutics Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Plasma Protein Therapeutics Players: Market Share by Revenue in 2023
Figure 21. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 24. North America Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 28. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 29. Germany Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Region (2019-2030)
Figure 36. China Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 47. Latin America Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Plasma Protein Therapeutics by Type (2019-2030)
Figure 57. Global Revenue Market Share of Plasma Protein Therapeutics by Type (2019-2030)
Figure 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Plasma Protein Therapeutics by Application (2019-2030)
Figure 60. Global Revenue Market Share of Plasma Protein Therapeutics by Application (2019-2030)
Figure 61. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2030)
Figure 62. Plasma Protein Therapeutics Value Chain
Figure 63. Plasma Protein Therapeutics Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed